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The short shelf-life of water-soluble quantum dots (QDs) due to
colloidal instability represents a major drawback to their exploitation.
This work examines the colloidal stability of PbS nanoparticles capped
with dihydrolipoic acid–polyethylene glycol (DHLA–PEG) ligands ter-
minated with functional groups such as –NH2, –COOH, OMe and –N3.
and their application for in vivo imaging. We prove a mechanism of
colloidal instability and develop a strategy to produce for the first time
stable PEG-capped PbS quantum dots with high quantum yield and
optical emission in the first and the second near-infrared (NIR) windows
of low absorption of biological tissues. The NIR imaging of in vivo
biodistribution is demonstrated at wavelengths 41000 nm, with ben-
efits of reduced tissue absorption and light scattering. The stability,
biocompatibility and potential for further QD functionalization open up
realistic prospects for non-invasive bioimaging applications.
The stability of colloidal nanoparticle solutions in physiological
solvents is a key prerequisite for their applications in bioimaging
and nanomedicine.1–3 Various nanomaterial systems have been
explored for medical imaging, including metal nanoparticles,4,5
upconverting nanoparticles6 and semiconductor quantum dots.7
Of particular interest is the development of biocompatible
colloidal quantum dots (QDs) with optical emission tuneable
in the near-infrared (NIR) wavelength range of reduced light
scattering and low absorption of biological tissues,8–10 which can
be achieved with IV–VI-based semiconductor materials (e.g. PbS,
PbSe).9,11 The important role of surface ligands for controlling
and designing functional nanomaterials has been widely
acknowledged.12,13 It has also been shown that the efficiency
of ligand binding to the surface of a nanocrystal has a strong
influence on QD polydispersity, quantum yield and photo-
stability.14,15 Polymer-based capping ligands that are biologically
inert, e.g. polyethylene glycol (PEG),3,16,17 have been successfully
used to produce a range of colloidal nanomaterials, from metal
nanoparticles to semiconductor QDs.13,16–19 However, the devel-
opment of capping ligands that can effectively passivate the
surface of a nanocrystal, provide longevity and colloidal stability,
do not alter its optical properties and allow controllable attach-
ment of functional molecules remains a challenge.13,20 On the
other hand, the modular attachment of PEG to dihydrolipoic
acid (DHLA) as the anchoring moiety of the ligand has been
shown to improve the passivation of nanoparticles, such as
AuNP and CdSe–ZnS QDs.21–24 Despite promising optical and
electronic properties, the technological exploitation of these
materials has stalled due to their short shelf-life caused by
colloidal instability.
Here we report the development of nanoparticles that com-
bine the beneficial biocompatibility and stability oﬀered by
DHLA–PEG-ligands with the tuneability of the emission of PbS
nanocrystals in the NIR wavelength range of low absorption of
biological tissues. We report on the stability of DHLA–PEG
ligands and their utilization for surface passivation of quantum
dots. We investigate the reasons for previously reported colloi-
dal instability and short shelf-life of colloidal solutions of thiol-
linked, PEG-capped nanoparticles We report time-dependent
nuclear magnetic resonance (NMR) studies of ligand molecules
and QDs, and suggest a strategy for the synthesis of stable
nanoparticle solutions. The DHLA–PEG ligands, modified with
functional groups including OMe, NH2, COOH and N3,
are used to synthesize colloidal PbS QDs in aqueous solution
with high quantum yield (B30%) and with room temperature
photoluminescence (PL) tuneable by the QD core size in the NIR
wavelength range, hence enabling enhanced light penetration
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through deep tissues and in vivo NIR imaging of QD biodistribu-
tion in mice. These results open up prospects for use of PbS–
DHLA–PEG QDs in biomedical applications where functional
groups can be used for the controllable attachment of targeting
molecules, such as peptides, small proteins or antibodies.
The ligands used in this work are composed of three parts
(Fig. 1a): DHLA, a PEG400 linker, and a functional group, R*,
such as OMe, NH2, COOH and N3,22,25 corresponding to
ligand molecules LOMe, LNH2, LCOOH and LN3, respectively.
PEG400 is a hydrophilic molecule that provides water solubility,
pH stability and biocompatibility of the QDs, and can be easily
changed for a diﬀerent chain length from PEG200 to PEG2000.
The stability and aging of ligand molecules has been assessed
by NMR time-course (Fig. 1 and ESI,† SI2). Our 1H-NMR studies
indicate that for the LNH2 and LN3 molecules, the spontaneous
oxidation of the DHLA and reformation of the disulfide bond of
its parent compound lipoic acid (LA) takes place with B70%
conversion over 48 h (Fig. 1a). A clear resurgence of the proton
signals at B2.45 ppm (Hb*) and at B3.18 ppm (Ha*/a0*) (see
Fig. 1b) is observed in LNH2, which are typical of the 5-
membered dithiolane ring containing the disulfide bond. At
the same time, the intensities of peaks at 2.71 ppm (Ha/a0) and
2.94 ppm (Hc), characteristic of DHLA, decrease. The change of
intensities is described by the first order kinetic regime with
comparable time constants (inset in Fig. 1b), as expected for the
interconversion reaction where DHLA is oxidized to LA. These
results indicate the inherent instability of LNH2 and LN3, which
is likely due to the interaction between the amine moiety and
the thiols.26,27 On the other hand, LOMe and LCOOH are stable
and do not undergo spontaneous oxidation (Fig. 1c and ESI,†
SI2) over the same observation period. The formation of the
disulfide bond prevents the ligand binding to the nanoparticle
surface, thus aﬀecting the colloidal stability of QDs.
Particular attention to the purification of the ligand mixture
is paramount for the stability of aqueous QD solutions. During
the ligand synthesis, the Staudinger reduction uses triphenyl
phosphine (Ph3P), generating triphenylphosphine oxide
(Ph3P(O)) as a by-product. The
31P NMR shows a clear peak at
29 ppm, confirming the presence of Ph3P(O) (ESI,† SI2). The
Ph3P(O)/Ph3P present in the reaction mixture can compete with
the DHLA–PEG as a QD capping molecule, thus altering the
aqueous solubility of the nanocrystals.28
We have used these DHLA–PEG capping ligands to produce
PbS quantum dots either in aqueous solution or in phosphate
buffered saline (PBS) (Fig. 2a) with sizes tuneable by the molar
ratio of Pb : S.29 For the Pb : S ratio of 1 : 0.3, the QDs have
average diameter dPbS = 3.2  0.8 nm (Fig. 2b). The dark field
TEM studies reveal the presence of a thick carbon-based
amorphous layer with non-uniform depth surrounding the
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Fig. 1 (a) Reaction scheme of the oxidation of the dithiols to the dithio-
lane ring; R is the remaining part of lipoic acid–PEG400-terminating
group. Representative 1H-NMR spectra of LNH2 (b) and LCOOH (c) for
freshly synthesised ligands and following 48 h storage, with corresponding
time dependence of the intensities of selected resonances.
Fig. 2 (a) Schematic representation of a nanoparticle capped with DHLA–
PEG-based ligands. (b) TEM and (inset) HR TEM images of PbS QDs
synthesized with LNH2 capping ligands and molar ratio Pb : S = 1 : 0.3. (c)
Room temperature photoluminescence (PL) spectra of freshly synthesized
(solid line) and 30-days-old (dashed line) PbS QDs (Pb : S = 1 : 0.3). Inset:
Room temperature PL spectrum of PbS QDs with molar ration of Pb : S =
1 : 0.3, synthesized with a mixture of LNH2 and LCOOH ligands in 1 : 3
molar ratio.
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PbS nanocrystal. The inter-particle distance value of Z2 nm
indicates interlocking of the DHLA–PEG between neighboring
nanocrystals on the surface.30,31 The average hydrodynamic
diameter of the QDs measured using dynamic light scattering
(DLS) is dQD = 11  1 nm, which is close to our estimate dQD =
dPbS + 2lE 13 nm, where lE 5 nm is the length of the extended
ligand molecule. The QD solutions prepared with molar ratio of
Pb : S = 1 : 0.3, have room temperature photoluminescence
centered at lPL = 920 nm, which is independent of the type of
ligand and/or ligand mixture used for surface passivation
(Fig. 2c).
By varying the Pb : S ratio from 1 : 0.3 to 1 : 0.6 we produce
quantum dots with a diameter ranging from dPbS E 3.2 nm to
5.5 nm, with corresponding PL emission tuneable in the NIR
range from 920 nm to 1220 nm, respectively (Fig. 3a). The PL
peak position and intensity are comparable for all ligands used,
irrespective of the specific terminating group (OMe, NH2,
COOH and N3) and only small time-dependent shift is
observed due to Ostwald ripening (Fig. 2c). All PbS QD solutions
have quantum yields of about 30% as measured using the
integrated sphere method (Edinburg Instrument spectrometer
FLS980 equipped with 120 mm diameter integrated sphere),
which is higher than that previously reported for other types of
PbS QDs.32 We note that stable colloidal solutions of PbS QDs
can also be produced with mixed ligands, e.g. LNH2 : LCOOH in
a 3 : 1 molar ratio (inset of Fig. 2c). The mixing of the ligands
has a potential benefit for the controlled attachment of diﬀer-
ent molecules. This in turn could allow greater selectivity, e.g.
attachment of complementary targeting molecules. Also, the
control of the ratio of functional groups on the QD surface
allows tuneability of the surface charge from positive for PbS–
LNH2 (z-potentialB 2.6  3.2 mV) to negative for PbS–LCOOH
QD (z-potential B 41.3  5.5 mV).
The QD solutions prepared using freshly synthesized ligands
have long-term colloidal stability (stored at T = 4 1C under
nitrogen atmosphere) over a period of at least 9 months. 1H-
NMR studies of these QD solutions show a clear resonances at
2.71 ppm (Ha/a0) and 2.94 ppm (Hc), characteristic for DHLA. In
stark contrast, when ligands were stored prior to the nanocrys-
tal synthesis, QD solutions precipitated within o10 days and
the 1H-NMR spectra of the supernatant confirmed the for-
mation of the dithiolane ring on the ligand molecules. Hence
the instability is due to lack of surface passivation by the
unreactive oxidized ligand molecules.
The potential of these QDs for bioimaging applications was
assessed by studies of the QD NIR emission penetration
through biological tissues. For these studies we selected the
QD solutions with PL at l 4 1000 nm to benefit from low
absorption of biological tissues and lower light scattering, thus
achieving deeper tissue penetration of the emitted light. To
account for the composition of diﬀerent tissues, we prepared
mouse brain and liver tissue slices with thicknesses ranging
from t = 0.2 mm to 4 mm. The slices were placed over two glass
capillaries of diameter d = 1 mm containing PbS–LNH2 solu-
tions with PL emission of comparable intensity centered at lPL
B 1050 nm (QD1) and at lPLB 1220 nm (QD2) (Fig. 3a). Fig. 3b
and c illustrate representative optical images of 0.5 mm thick
brain and liver slices, respectively, placed over the capillaries.
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Fig. 3 (a) Room temperature PL spectra of PbS–LNH2 nanocrystals QD1 (orange spectrum) and QD2 (red spectrum). The highlighted areas indicate the
wavelength range where PL images through the tissues are acquired. Optical images and corresponding PL images of QD loaded capillary tubes overlaid
with (b) brain and (c) liver tissue slices of thickness t = 0.5 mm. PL images were acquired with excitation wavelength lex = 670 nm and bandpass filters at
(1000  25) nm and at (1300  25) nm. (d) PL intensity measured through the liver tissues versus the tissue thickness at l = 1000 nm and l = 1300 nm.
Dashed lines are guide to the eye.
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The corresponding PL maps were acquired at l = 1000  25 nm
(middle images) and at 1300  25 nm (bottom images). They
demonstrate that the NIR fluorescence of the QDs can be
detected through all studied tissues.
However, the observed decrease of light intensity through
tissues is significantly greater for high-blood-content tissues,
such as liver, compared to brain. For example, for brain tissues
of thickness t = 0.5 mm, no measurable decrease of optical
signal was detected compared to capillary only. For the same
thickness of liver tissue, about 5-times decreased intensity was
observed at l = 1000 25 nm and 2-times decreased intensity at
l = 1300  25 nm (Fig. 3d). The use of longer wavelengths
enables better imaging through liver, with B1.5 times higher
resolution achieved for all tissue thicknesses (Fig. 3c and ESI,†
SI3) due to reduced scattering.8,33 We also note that a signal to
noise ratio ofZ3 was achieved for liver tissue of thicknesses up
to 4 mm. The observed signal penetration depth confirms the
suitability of these QDs for non-invasive imaging.
In order to guide the in vivo studies, we assessed the
cytotoxicity of these QDs in vitro by MTT assay. Prior to cell
culture and in vivo studies, we dialyse the QD solutions against
PBS and lower the pH. We note that this process does not alter
the colloidal stability and photostability of the QDs. Previously,
PbS QDs were reported to induce greater toxicity in tumorigenic
cell lines compared to normal cells.29,34 We selected three
human derived carcinoma cell lines: MDA-MB-231 and MCF-7
breast, and HCT-116 colorectal cells. Assessment after 72 h
exposure of cells to PbS QDs demonstrated that in all three cell
lines, neither cell viability nor cell growth were compromised at
PbS QD concentrationsr20 mg mL1 (see ESI,† SI3). The acute
toxicity studies over a period of 30 days have not revealed any
QD-induced toxic eﬀects in mice.34 No indication of damage to
the organs/tissues was found in histological examination of
internal organs at the end of the study, confirming the stability
of QDs in vivo and the absence of release of heavy metal ions
from the QDs.
The in vivo biodistribution of QDs was observed using NIR
fluorescence. Mice were injected via tail vein with 30 mL of 0.2
mM PbS QD solution, corresponding to a final concentration of
approximately 10 mg mL1 (2-times lower than the GI50 value).
Fig. 4a illustrates typical NIR images (l4 1000 nm) of PbS QDs
(LNH2) in blood vessels in a mouse head immediately after the
injection. The fluorescence in the brain vessels fades within a
few minutes and the emission in not detectable upon inspec-
tion of the brain ex vivo 48 h after injection, indicating that
these QDs do not pass the blood–brain barrier.
Within 1 hour, measurable NIR fluorescence was observed
in the areas of liver and spleen. Fig. 4b illustrates a typical
biodistribution of the PbS QDs, as detected with NIR fluores-
cence 24 hours after the QD injection. The intensities of the
fluorescence signal observed in liver and in spleen are compar-
able when measured in vivo (see top insets in Fig. 4b) and
ex vivo in the corresponding organs (see lower insets of Fig. 4b).
In agreement with our tissue penetration studies, the in vivo
fluorescence intensity is about 2-times lower compared to the
ex vivo value. We note that, as expected, NIR fluorescence was
only detected in QD injected animals (see ESI,† SI3). Following
48 h exposure, the intensity of the optical signal from both liver
and spleen decreased by a factor of B3 compared to that
measured after 24 h exposure. We attribute the observed
decrease of fluorescence to gradual clearance of QDs from the
body. Indeed in some mice, significant fluorescence was
observed in the bladder area, indicating that QDs are cleared
from the body via the urinary tract. There is also some indica-
tion that after 48 h some QDs might be present in lymph nodes,
as was also reported previously.33,35 We exclude the possibility
that the decrease in fluorescence intensity is due to interactions
of QDs with proteins in blood/serum (e.g. with albumin), as we
prepare our QDs with excess ligands to ensure eﬃcient passiva-
tion of the surface in order to eliminate such interactions. Also,
even in the case of QD binding to proteins in serum, the formed
complexes are reported to be both soluble and photostable.36
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Fig. 4 (a) Photograph of a mouse head and a corresponding NIR fluorescence image of blood vessels in the head immediately after tail vein injection of
LNH2 capped QDs (PL centred at 1050 nm). (b) Whole body and corresponding intensity surface, and ex vivo NIR fluorescence images of liver (left inset)
and spleen (right inset) of a mouse 24 h after tail vein injection of LNH2 capped QDs (PL centred at 1220 nm). NIR images were acquired with excitation
laser at lex = 670 nm (P = 10 W m
2), InGaAs CMOS camera and a long pass filter at 1000 nm.
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We note that over the duration of the study, the QDs were
well tolerated by mice. No distress or noticeable physiological
changes were observed. Also, mice organs (liver, spleen, brain,
kidneys, lungs and heart) were inspected after 24 h and after 48
h, and no visible morphological changes were observed. Ex vivo,
measurable fluorescence was detected only in spleen and liver
(lower insets in Fig. 4b). Importantly, no noticeable fluores-
cence was detected in kidneys, indicating that QDs do not
accumulate and are well cleared via the kidneys. No noticeable
changes in QD biodistribution and in fluorescence intensity
were observed for QDs capped with ligands terminated with
diﬀerent functional groups.
In our preliminary studies, we have successfully attached
folic acid and cyclic RGD peptides, as cellular targeting ligands,
using –NH2 and –N3 terminated ligands, respectively, and
produced nanoparticles with these functionalized ligands.
Further work is underway to explore the targeting efficiency
of these functionalized nanocrystals in tumour bearing mice
and to fully assess the potential of these QDs for bioimaging
applications.
Conclusions
In conclusion, we have identified and addressed the causes that
trigger the instability of colloidal nanoparticles capped with
DHLA–PEG-based ligands, i.e. LOMe, LNH2, LN3, LCOOH or
their mixtures. Also, we have successfully used these molecules
to produce stable and biocompatible PbS QDs with optical
emission tuneable in the near-infrared wavelength range. The
QDs are well tolerated by mice in vivo and their emission can be
imaged in the second NIR optical window. Our findings are
transferable to other types of semiconductor and metal nano-
particles and offer potential for further functionalization of the
nanocrystals for a wide range of biomedical applications.
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